Stay updated on CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial
Sign up to get notified when there's something new on the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page.

Latest updates to the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the typical study record content with an access message. Core elements such as sponsor details, eligibility criteria, locations, and outcomes are no longer visible due to the error.SummaryDifference18%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.6.6 replaces v3.6.5 as the page's version marker, indicating a small update to the site's code or content management. No changes to the study details, eligibility criteria, or results are introduced.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision: v3.6.5 appears, replacing Revision: v3.6.4. This indicates a newer build of the page without changes to the study information.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision tag updated to v3.6.4 on the page, reflecting a deployment-level change from the previous revision.SummaryDifference0.1%

- Check88 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2, indicating an update to the page's revision label.SummaryDifference0.1%

- Check95 days agoChange DetectedThe page shows a new revision label (v3.6.2) replacing the previous v3.6.0, indicating a minor update to the ClinicalTrials.gov page.SummaryDifference0.1%

Stay in the know with updates to CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page.